Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Schedule of Anti-dilutive Securities (Details)

v3.24.2.u1
Net Income (Loss) Per Share - Schedule of Anti-dilutive Securities (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Prefunded Warrants        
Anti-dilutive securities        
Weighted average of warrants outstanding (in shares)   2,192   1,338
Warrants outstanding (in shares) 0   0  
Stock options        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 156,940 7,706 156,940 7,706
Warrants on common stock        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 148 17,237 148 17,237
Series C Preferred Stock (as-converted to common stock)        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 22,357,897 0 22,357,897 0
Preferred Stock, convertible, shares issuable in common stock (in shares) 1,000   1,000